We enable safe and efficient monitoring of tissues during cancer surgery without compromising workflows.
Rethinking surgery.
Marginum is developing groundbreaking tissue recognition technology, especially for oncological surgery.
Our technology assists in safe and efficient identification of cancerous tissue with minimal damage to healthy tissues.
Precise detection of tissue without additional invasive steps – based on internationally awarded research.
3.11.2025 | BUSINESS FINLAND
Marginum has been selected for the prestigious Young Innovative Companies (YIC) program, a recognition reserved for Finland’s most promising startups.
20.10.2025 | MARGINUM NEWS
Marginum has completed the HIVEN® usability assessment at the University of Illinois College of Medicine Surgical Innovation and Training Laboratory.
15.10.2025 | Marginum News
Thomy F.E., d.o.o., one of Slovenia’s leading distributors of advanced medical and surgical technologies, has formed a strategic partnership with Marginum.
3.10.2025 | Redacción Médica
MBA SURGICAL EMPOWERMENT, a leading Spanish distributor in the medical-surgical technology sector, has partnered with Marginum.
25.9.2025 | BUSINESS WIRE
Marginum receives MDR certification and releases the first-of-a-kind HIVEN® device, bringing the technology to clinical use in the EU.
22.8.2025 | Talouselämä
Marginum raises €2.5M in Pre-Series A funding to expand HIVEN® into European markets and acquire U.S. FDA clearance.
Marginum is enabling better surgical performance and patient outcomes to answer the globally growing need for efficient oncological treatments.
Founded in 2020, Marginum is reforging the
technology of oncological surgery.
With the developed tissue detection technology for surgery, Marginum aims to make a real impact by helping millions of patients and surgical professionals around the globe.
Location: Kuopio, Finland
Email: info@marginum.com